Navigation Links
Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
Date:8/29/2007

SAN CARLOS, Calif., Aug. 29 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that Mr. Lutz Lingnau has been appointed to serve on its board of directors. Lingnau is a highly-respected pharmaceutical industry leader with over 35 years of experience in corporate management, product development and marketing.

"Lutz Lingnau brings to Nektar extensive pharmaceutical development and commercialization experience at an important point in the company's evolution," said Howard W. Robin, President and CEO of Nektar. "As we continue to drive our proprietary programs through the clinic, it is imperative that we leverage the strategic guidance of leaders like Lutz who have a proven track record of bringing successful therapeutics to market."

Most recently, Lingnau was a member of the Executive Board at Schering AG and Vice Chairman, President and CEO of Schering Berlin, Inc. While at Schering AG, he was responsible for the worldwide specialized therapeutics business and also held a number of other executive positions including Head of Worldwide Sales and Marketing in the Pharmaceutical Division, and Chairman and President of Berlex Laboratories, Inc.

"Nektar's innovative development of therapeutics using its proprietary PEGylation and pulmonary technologies is among the most important areas in biopharmaceutical drug development," Lingnau said. "I look forward to working with Howard and his executive team as they move Nektar's clinical pipeline forward and advance the company's strategic business objectives."

Lingnau is also currently a member of the Supervisory Board of LANXESS AG, Germany and Chairman of the Board of Directors of Micropharma Ltd., Montreal. He was formerly a memb
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Sharon Ethanol appoints operations director
3. Kyron appoints former AMA chairman to board
4. Brady appoints GE efficiency expert as CTO
5. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
6. Johnson Controls appoints Roell to head EOC
7. SecurePipe appoints two senior execs
8. Milwaukees PointOne appoints new president and CEO
9. Third Wave appoints new chairman
10. Midwest Venture Summit disappoints; Cato grades Midwest governors
11. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,November24/PRNewswire-FirstCall/--deCODE,genetics...ofits,"firstday"motionsbytheU.S.BankruptcyCourtfor...Elastweekfiledavoluntarypetitionfor,reliefunderCha...uptcyCourt. , TheordersissuedbytheBankruptcyC...duringtheChapter11proceedings.Inparticular,the,com...
(Date:11/24/2009)...Newswire/--BlueMarbleEnergyCorp.announcedtodaythat...PDA)wererecentlyawarded$2millionbyWashingtonState,...ate/publicpartnershiptoconstructthestate,sfirstspe..., "Thisinvestmentwillsignificantlyspeedthedevelo...olnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."We...
(Date:11/24/2009).../PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: ...,today,announcedthatithassubmittedaMAAtotheEuropea...enzymereplacementtherapyindevelopment,forthetreatm...pplicationforvelaglucerasealfathathasbeensubmitted...a. , Basedonaglobalsupplyshortageofthecurrent...
(Date:11/24/2009)... Program Connects Customers with Partners Validate...A Genotek Products , Otta... a leading provider of products for biological sam...ay announced its new global partner program. The p...otek,s partner community and is designed to help p...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...h,announced that Sustenex(TM), its all-natural dai...e. Each Sustenex(TM) capsule contains at least 2,b...rietary, patented strain,of Bacillus coagulans des.... Sustenex(TM) with GanedenBC30 Probiotic is desig...elivering ten times more probiotic cells,than most...
...egic and operational leadership to support expans... opportunities, COLUMBIA, Md., A...ent of Brad L. Stewart as President of the Company...elops and manufactures research and in,vitro diagn... assay,cell-mediated immunity (CMI)., (Photo: ht...
...e,Chairman and CEO, Egenix, Inc., announced the ap...e company,s scientific advisory board. Dr.,Petryla...Columbia,University Medical Center where he is Dir...l Oncology. He is the co-author of numerous peer r... in the treatment of cancers of,prostate, kidney, ...
Other Biology Technology:Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic 2Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic 3Cylex Announces Brad L. Stewart as President of the Company 2
(Date:11/24/2009)...et science is opening new doors to understanding h...the hearing of a marine mammal or if they hear it...ed X-ray scanners that NASA uses to detect flaws i...is now allowing scientists to peek inside the gian...d three-dimensional replicas of a whale,s hearing ...
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wi...a report revealing that the last remaining populat...cantly due to the rising tide of poaching and habi... help inform Russian officials of what needs to be...d,s biggest cat. , The report was r...
(Date:11/23/2009)...INNATINew research presents strong evidence that t...both outdoor traffic-related pollution and indoor ...n one or the other exposure alone. , Environme...nati (UC) College of Medicine have shown that chil...d particles and indoor endotoxin during early life...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Predictors of disease behavior change in Crohn 26 23146 3Bs disease 54046 1Estrogen dependent switch tempers killing activity of immune cells 9527 1Estrogen dependent switch tempers killing activity of immune cells 9527 2STAT3 gene regulates cancer stem cells in brain cancer 9525 1STAT3 gene regulates cancer stem cells in brain cancer 9525 2
...terdam, 2 December 2008 - Elsevier is delighted to...e the official publisher of the quarterly peer-rev... ( www.elsevier.com/locate/esd ) on behalf of the ...nable development involves meeting present human n...ons. Energy is central to providing many of these ...
... Arctic is undergoing rapid transformation due to ...s ERS and Envisat satellites have been providing s... These long term data sets in combination with ESA... newly adopted European Commission policy called ,...policy highlights new opportunities in the region ...
...PEL HILL How marine animals find their way back t...ross thousands of miles of open ocean has mystifie...iologists at the University of North Carolina at C... the secret. , At the beginning of their lives, s...of their home area and "imprint" on it, according ...
Other Biology News:New publishing partnership for Energy for Sustainable Development 2ESA satellites focusing on the Arctic 2No place like home: New theory for how salmon, sea turtles find their birthplace 2No place like home: New theory for how salmon, sea turtles find their birthplace 3
Costar 6 Well Cell Culture Plate, 9.5 cm2, 34.8 mm Diam. Well, Sterile from Sigma-Aldrich
Rabbit Anti-GABA A Receptor gamma 2 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-VIP Receptor 2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Rat Golgi Snap Receptor Complex Member 2 (GOSR2) Monoclonal Antibody, Unconjugated from Lifespan Biosciences
Biology Products: